Valuation: Mega Lifesciences

Market Cap 32.26B 962M 844M 779M 720M 1.36B 92.14B 1.39B 9.37B 3.64B 45.09B 3.61B 3.53B 157B P/E 2026 *
13.9x
P/E 2027 * 13.1x
Enterprise Value 27.41B 817M 717M 662M 612M 1.16B 78.28B 1.18B 7.96B 3.09B 38.31B 3.07B 3B 133B EV / Sales 2026 *
1.84x
EV / Sales 2027 * 1.76x
Free-Float
38.61%
Yield 2026 *
4.79%
Yield 2027 * 5.07%
1 day-1.99%
1 week-1.99%
Current month+0.68%
1 month+4.96%
3 months+8.82%
Current year+10.45%
1 week 36.5
Extreme 36.5
38
1 month 33.75
Extreme 33.75
38
Current year 31.5
Extreme 31.5
40
1 year 25.75
Extreme 25.75
40
3 years 24.3
Extreme 24.3
46.75
5 years 24.3
Extreme 24.3
56.5
10 years 15.9
Extreme 15.9
56.5
Manager TitleAgeSince
Chief Executive Officer 64 01/01/1988
Director of Finance/CFO 61 01/01/1997
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 55 13/05/2021
Director/Board Member 72 01/01/1982
Director/Board Member 69 01/02/2013
Date Insider Type Main position Quantity % Market Cap.
29/04/25Buy

Chief Executive Officer

100,000 0.0115%
28/04/25Buy

Chief Executive Officer

150,000 0.0172%
28/04/25Buy

Chief Executive Officer

50,000 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
-1.99%-1.99%+37.04%-1.99% 962M
-1.60%+2.02%+56.34%+168.94% 1,084B
-1.44%+3.71%+69.07%+65.40% 634B
-0.75%+0.67%+33.18%+86.52% 447B
-0.37%-2.31%+28.31%+25.77% 330B
-8.90%-11.07%+24.76%+26.99% 295B
-0.54%-2.17%+28.39%+46.00% 285B
-0.77%-3.24%-27.49%-39.49% 218B
-0.03%+1.84%+23.90%+68.30% 199B
-0.40%+7.82%+22.29%+82.50% 169B
Average -1.68%+2.14%+29.58%+52.90% 366.08B
Weighted average by Cap. -1.68%+2.48%+40.15%+85.14%

Financials

2026 *2027 *
Net sales 14.88B 444M 389M 359M 332M 629M 42.49B 642M 4.32B 1.68B 20.79B 1.67B 1.63B 72.18B 15.61B 466M 408M 377M 348M 660M 44.59B 674M 4.53B 1.76B 21.82B 1.75B 1.71B 75.75B
Net income 2.32B 69.2M 60.7M 56.04M 51.78M 98.15M 6.63B 100M 674M 262M 3.24B 260M 254M 11.26B 2.46B 73.38M 64.36M 59.42M 54.91M 104M 7.03B 106M 714M 278M 3.44B 276M 270M 11.94B
Net Debt -4.85B -145M -127M -117M -108M -205M -13.86B -209M -1.41B -547M -6.78B -544M -532M -23.54B -4.76B -142M -124M -115M -106M -201M -13.58B -205M -1.38B -537M -6.65B -533M -521M -23.08B
Logo Mega Lifesciences
Mega Lifesciences Public Company Limited is a Thailand-based company, which is engaged in health and wellness industry. Its segments include Brands, Distribution and OEM. MEGA We Care is its branded products business, through which it develops, manufactures, markets and sells its own range of nutraceuticals, complementary medicines, prescription pharmaceuticals and over the counter (OTC) health products. Maxxcare serves as its prominent distribution arm, specializing in the marketing, sales, and distribution of a range of branded prescription pharmaceuticals, OTC medications and fast-moving consumer goods (FMCG) across key markets such as Myanmar, Vietnam and Cambodia. Its suite of services encompasses warehouse management, collections and value-added initiatives, including tailored marketing services for principals in the pharmaceutical and FMCG sectors. Its manufacturing facilities in Thailand, Australia and Indonesia also accept production orders from various third-party customers.
Employees
-
Date Price Change Volume
08/07/26 THB 37.00 -1.99% 1,334,709
07/07/26 THB 37.75 -0.66% 541,492
06/07/26 THB 38.00 +0.66% 1,022,371
03/07/26 THB 37.75 +0.67% 734,293
02/07/26 THB 37.50 -0.66% 585,090
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
37.00THB
Average target price
41.14THB
Spread / Average Target
+11.20%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEGA Stock